A short burst of oral corticosteroid for children with acute asthma: Is there an impact on immunity?

Pediatric, Allergy, Immunology, and Pulmonology

Volumn 23, Issue 4, 2010, Pages 243-252

  Ducharme, Francine M ^a,b   Ochs, Hans D ^c   Resendes, Sandy ^b   Zhang, Xun ^d   Mazer, Bruce D ^e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; DIPHTHERIA ANTIBODY; DIPHTHERIA TETANUS VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; PREDNISONE; SALBUTAMOL; TETANUS ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; ASTHMA; BACTERIOPHAGE PHI X 174; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIPHTHERIA; EMERGENCY WARD; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TETANUS;

EID: 79951821201     PISSN: 2151321X     EISSN: 21513228     Source Type: Journal    
DOI: 10.1089/ped.2010.0041     Document Type: Article

References (45)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2008 (available at www .ginasthma.org, accessed August 10, 2010).
2. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Asthma Education and Prevention Program No. 07-4051. National Institutes of Health, 2007 (available at www.nhlbi.nih.gov/ guidelines/asthma/asthgdln.htm, accessed August 14, 2010).
3. Smith M, Iqbal SMSI, Rowe BH, NDiaye T. Corticosteroids for hospitalised children with acute asthma. Cochrane Database of Systematic Reviews 2003, Issue 1, Art. No.: CD002886. DOI: 10.1002/14651858.CD002886.
4. Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CAJ. Corticosteroid therapy for acute asthma. Respir Med 2004; 98:275-284. (Pubitemid 38443686)
5. Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics 2003; 111:376-383. (Pubitemid 36177159)
6. Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008; 122:e53-e61.
7. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J 1990; 9:729-732. (Pubitemid 20335445)
8. Coburg AJ, Gray SH, Katz FH, Penn I, Halgrimson C, Starzl TE. Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet 1970; 131:933-942.
9. Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest 1973; 52:2629-2640.
10. Van Schoor J, Toogood JH, Pauwels RA. Short courses of highdose inhaled budesonide and serum IgG subclass levels in healthy volunteers. J Allergy Clin Immunol 1996; 97:113-118. (Pubitemid 26045975)
11. Posey WC, Nelson HS, Branch B, Pearlman DS. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol 1978; 62:340-348. (Pubitemid 9096370)
12. Van Schoor J, Toogood JH, Pauwels RA. Differential effects of inhaled budesonide and oral prednisolone on serum immunoglobulin G and its subclasses in healthy adult volunteers. Clin Exp Allergy 1997; 27:192-195. (Pubitemid 27085420)
13. Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumpsrubella vaccination. Pediatrics 2003; 112:e98-e103.
14. Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med 1998; 152:1191-1195. (Pubitemid 28558105)
15. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98:196-200. (Pubitemid 26262129)
16. Patel H, Macarthur C, Johnson D. Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children. Arch Pediatr Adolesc Med 1996; 150:409-414. (Pubitemid 26109224)
17. Dowell SF, Bresee JS. Severe varicella associated with steroid use. Pediatrics 1993; 92:223-228. (Pubitemid 23226836)
18. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1986;225-244.
19. Wedgwood RJ, Ochs HD, Davis SD. The recognition and classification of immunodeficiency diseases with bacteriophage phiX Birth Defects Orig Artic Ser 1975; 11:331-338.
20. Fogelman I, Davey V, Ochs HD, et al. Evaluation of CD4 T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization. J Infect Dis 2000; 182: 435-441. (Pubitemid 30651039)
21. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Experiment Immunol 1997;109:1-28.
22. Wilson NW, Ochs HD, Peterson B, Hamburger RN, Bastian JF. Abnormal primary antibody responses in pediatric trauma patients. J Pediatr 1989; 115:424-427. (Pubitemid 19223180)
23. Lack G, Ochs HD, Gelfand EW. Humoral immunity in steroiddependent children with asthma and hypogammaglobulinemia. J Pediatr 1996; 129:898-903. (Pubitemid 27500369)
24. Shearer WT, Lugg DJ, Rosenblatt HM, et al. Antibody responses to bacteriophage phi X-174 in human subjects exposed to the antarctic winter-over model of spaceflight. J Allergy Clin Immunol 2001; 107:160-164. (Pubitemid 32105260)
25. Bearden CM, Agarwal A, Book BK, et al. Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant 2005; 5:50-57. (Pubitemid 40095127)
26. Ochs HD, Davis SD, Wedgwood RJ. Immunologic responses to bacteriophage 0-174 in immunodeficiency diseases. J Clin Invest 1971; 50:2559-2568.
27. Pyun HK, Ochs HD, Wedgwood RJ, Yang XQ, Heller SR, Reimer CB. Human antibody responses to bacteriophage 0- 174: sequential induction of IgM and IgG subclass antibody. Clin Immunol Immunopathol 1989; 51:252-263.
28. Grubb R, Swahn B. Destruction of some agglutinins but not of others by two sulfhydryl compounds. Acta Pathol Microbiol Scand 1958; 43:305-309.
29. Product Monograph. Virotech ELISA systems for detection of diptheria and tetanus, Russelsheim, Germany, 1994.
30. McCusker C, Somerville W, Grey V, Mazer B. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. Ann Allerg Asthma Immunol 1997; 79:145-150. (Pubitemid 27375288)
31. Ducharme FM, Chalut D, Plotnick L, et al. The pediatric respiratory assessment measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr 2008; 152:476-480.
32. Ducharme FM, Davis GM, Noya F, Rich H, Ernst P. The Asthma Quiz for Kidz: A validated tool to appreciate the level of asthma control in children. Can Respir J 2004; 11:541-546. (Pubitemid 40089890)
33. Wolfe R, Carlin JB. Sample-size calculation for a log-transformed outcome measure. Control Clin Trials 1999; 20:547-554. (Pubitemid 30001694)
34. DAgostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281.
35. Kawano T, Matsuse H, Obase Y, et al. Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol 2002; 128:240-243. (Pubitemid 34765231)
36. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993; 178:1097-1102. (Pubitemid 23260449)
37. Kurashima K, Fujimura M, Myou S, et al. Effects of oral steroids on blood CXCR3 and CCR4 T cells in patients with bronchial asthma. Am J Respir Crit Care Med 2001; 164:754-758. (Pubitemid 32881909)
38. Muller I, Aepinus C, Beck R, Bultmann B, Niethammer D, Klingebiel T. Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol 2001; 37:145-147. (Pubitemid 32738079)
39. Grant CC, Duggan AK, Santosham M, Deangelis C. Oral prednisone as a risk factor for infections in children with asthma. Arch Pediatr Adolesc Med 1996; 150:58-63. (Pubitemid 26022156)
40. Cooper WO, Staffa JA, Renfrew JW, Graham DJ, Ray WA. Oral corticosteroid use among children in TennCare. Ambul Pediatr 2002; 2:375-381. (Pubitemid 35153686)
41. Davis MM, Patel MS, Gebremariam A. Decline in varicellarelated hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114:786-792. (Pubitemid 41529540)
42. Nightingale SL. From the Food and Drug Administration- Warning on varicella added to corticosteroid drug products labeling. JAMA 1992; 267:339.
43. Levy J, Zalkinder I, Kuperman O, et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol 1995; 95:806-812.
44. Masten B, McWilliams B, Lipscomb M, et al. Immune response to hepatitis B vaccine in asthmatic children. Pediatr Pulmonol 2003; 36:522-528. (Pubitemid 37523392)
45. Gershon AA, LaRussa P. Varicella-Zoster virus infections. In: Gershon AA, Hotez PJ, Katz SA, eds. Krugmans Infectious Diseases of Children, 11th edition. Philadelphia: Mosby, 2000, pp. 800-801.